Jian Sheng
Jian Sheng has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Chenyang Han
Department of Pharmacy The Second Affiliated Hospital of Jiaxing University Jiaxing Zhejiang China
4 shared publications - Rui Du
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China; College of Agriculture, Yanbian University, Yanbian 133002, China; Jilin Provincial Engineering Research Center for Efficient Breeding and Product Development of Sika Deer, Changchun 130118, China; Key Laboratory of Animal Production and Product Quality and Security, Ministry of Education, Ministry of National Education, Changchun 130118, China
3 shared publications Wenyan Li
Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, China
3 shared publicationsHongyan Pei
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China
2 shared publications- Hongyan Pei
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China
2 shared publications Jin Wang
The Second Affiliated Hospital of Jiaxing University Jiaxing China
2 shared publications
Latest Publications
- 15 February 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 150, 114284
Deer antler polypeptides inhibit microglial activation via TREM2 to improve behavior and neuroinflammation in CUMS mice
- 15 February 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 150, 114284
Deer antler polypeptides inhibit microglial activation via TREM2 to improve behavior and neuroinflammation in CUMS mice
- 17 June 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (1) , 583-590
Polypeptide-PNP2 in Corn Cervi Pantotrichum Ameliorates Cognitive Impairment in Alzheimer’s Disease Mice by Inhibiting Microglial Cell Activation
We isolated a polypeptide PNP2 from Corn Cervi Pantotrichum and investigated its effect and mechanism on cognitive impairment in Alzheimer’s disease (AD) mice. Morris water maze was used to assess the degree of cognitive impairment in mice. Histopathological changes were detected by H&E staining; the expressions of inflammatory cytokines were assayed by ELISA. Western blotting was employed to detect the protein expressions. PNP2 could improve cognitive impairment, central inflammatory response, and NLRP3 signaling in AD mice. In vitro experiments revealed that PNP2 could suppress the inflammatory response of microglial cells and reduce the activation of NLRP3 in microglial cells, while MCC950 could antagonize the effects of PNP2. Polypeptide component PNP2 in Corn Cervi Pantotrichum can ameliorate central nervous inflammation and cognitive impairment in AD mice by suppressing NLRP3 signaling.
- 17 June 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (1) , 583-590
Polypeptide-PNP2 in Corn Cervi Pantotrichum Ameliorates Cognitive Impairment in Alzheimer’s Disease Mice by Inhibiting Microglial Cell Activation
We isolated a polypeptide PNP2 from Corn Cervi Pantotrichum and investigated its effect and mechanism on cognitive impairment in Alzheimer’s disease (AD) mice. Morris water maze was used to assess the degree of cognitive impairment in mice. Histopathological changes were detected by H&E staining; the expressions of inflammatory cytokines were assayed by ELISA. Western blotting was employed to detect the protein expressions. PNP2 could improve cognitive impairment, central inflammatory response, and NLRP3 signaling in AD mice. In vitro experiments revealed that PNP2 could suppress the inflammatory response of microglial cells and reduce the activation of NLRP3 in microglial cells, while MCC950 could antagonize the effects of PNP2. Polypeptide component PNP2 in Corn Cervi Pantotrichum can ameliorate central nervous inflammation and cognitive impairment in AD mice by suppressing NLRP3 signaling.
- 12 July 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 247, 125815
Protection of a novel velvet antler polypeptide PNP1 against cerebral ischemia-reperfusion injury
- 12 July 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 247, 125815
Protection of a novel velvet antler polypeptide PNP1 against cerebral ischemia-reperfusion injury
- 30 May 2023
- Published by Wiley in Liver International
- Vol. 43 (7) , 1604-1613
Double‐negative T cells regulate the progression of liver fibrosis through Th9 cells differentiation
Our previous study found that double negative T cells (DNTs) could promote the NLRP3 activation through high expression of TNF‐α, thereby leading to hepatic fibrosis progression. We focused on investigating the role and mechanism of DNTs in regulating the Th9 cells differentiation in liver fibrosis. In our results, among patients with liver fibrosis, the proportions of peripheral blood DNTs and Th9 cells were up‐regulated and positively correlated. While promoting the progression of liver fibrosis in mice, DNTs could elevate the proportion of Th9 cells and activate the TNFR2‐STAT5‐NF‐κB pathway. The use of IL‐9 and TNF‐α monoclonal antibodies (mAbs) inhibited the effect of DNTs and lowered the proportion of Th9 cells in tissues. In vitro experiments showed that DNTs could promote the Th9 cells differentiation of Naive T cells, while TNF‐α mAbs could inhibit such effect of DNTs to lower the proportion of Th9 cells. We found that DNTs can activate TNFR2‐STAT5‐NF‐κB pathway by secreting TNF‐α, thereby promoting the Th9 Cells differentiation to facilitate the progression of liver fibrosis. There is interaction between DNTs and Th9 cells.
- 30 May 2023
- Published by Wiley in Liver International
- Vol. 43 (7) , 1604-1613
Double‐negative T cells regulate the progression of liver fibrosis through Th9 cells differentiation
Our previous study found that double negative T cells (DNTs) could promote the NLRP3 activation through high expression of TNF‐α, thereby leading to hepatic fibrosis progression. We focused on investigating the role and mechanism of DNTs in regulating the Th9 cells differentiation in liver fibrosis. In our results, among patients with liver fibrosis, the proportions of peripheral blood DNTs and Th9 cells were up‐regulated and positively correlated. While promoting the progression of liver fibrosis in mice, DNTs could elevate the proportion of Th9 cells and activate the TNFR2‐STAT5‐NF‐κB pathway. The use of IL‐9 and TNF‐α monoclonal antibodies (mAbs) inhibited the effect of DNTs and lowered the proportion of Th9 cells in tissues. In vitro experiments showed that DNTs could promote the Th9 cells differentiation of Naive T cells, while TNF‐α mAbs could inhibit such effect of DNTs to lower the proportion of Th9 cells. We found that DNTs can activate TNFR2‐STAT5‐NF‐κB pathway by secreting TNF‐α, thereby promoting the Th9 Cells differentiation to facilitate the progression of liver fibrosis. There is interaction between DNTs and Th9 cells.
- 24 April 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110179
Imidacloprid activates Kupffer cells pyroptosis to induce liver injury in mice via P2X7
- 24 April 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110179
Imidacloprid activates Kupffer cells pyroptosis to induce liver injury in mice via P2X7